INmune Bio Inc. (INMB)
NASDAQ: INMB
· Real-Time Price · USD
5.41
-0.87 (-13.85%)
At close: Jun 27, 2025, 1:38 PM
-13.85% (1D)
| Bid | 5.17 |
| Market Cap | 125.58M |
| Revenue (ttm) | 50K |
| Net Income (ttm) | -40.8M |
| EPS (ttm) | -1.93 |
| PE Ratio (ttm) | -2.8 |
| Forward PE | -4.34 |
| Analyst | Buy |
| Ask | 5.58 |
| Volume | 51,860,761 |
| Avg. Volume (20D) | 495,680 |
| Open | 9.31 |
| Previous Close | 6.28 |
| Day's Range | 5.20 - 11.64 |
| 52-Week Range | 4.32 - 11.64 |
| Beta | 1.57 |
About INMB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INMB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for INMB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts48 minutes ago
INMB stock has given up its prior gain. INmune Bio...
Unlock content with
Pro Subscription
5 hours ago
INmune Bio shares are trading higher after the company revealed top-line results from its MINDFuL Phase 2 trial.
